公开(公告)号：US20130123280A1

公开(公告)日：2013-05-16

申请号：US13666826

申请日：2012-11-01

Applicant: Gilead Sciences, Inc.

Inventor： Rao V. Kalla ,  Thao Perry ,  Elfatih Elzein ,  Vaibhav Varkhedkar ,  Xiaofen Li ,  Prabha N. Ibrahim ,  Venkata Palle ,  Dengming Xiao ,  Jeff Zablocki

IPC: C07D473/06 ,  C07D473/04

CPC classification number: C07D473/06 ,  A61K31/522 ,  C07D473/04

Abstract: Disclosed are novel compounds that are A2B adenosine receptor antagonists, useful for treating various disease states, including asthma and diarrhea.

Abstract translation: 公开了作为A2B腺苷受体拮抗剂的新型化合物，其可用于治疗各种疾病状态，包括哮喘和腹泻。